v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenue $ 11,284 $ 2,336
Cost of revenue 13,645 6,781
Gross loss (2,361) (4,445)
Operating expenses:    
Research and development 2,003 1,581
Selling, general and administrative 5,307 4,293
Total operating expenses 7,310 5,874
Loss from operations (9,671) (10,319)
Other income, net 300 433
Net loss $ (9,371) $ (9,886)
Weighted-average common shares outstanding:    
Weighted-average common shares outstanding, basic (in shares) 117,969,812 90,029,320
Weighted-average common shares outstanding, diluted (in shares) 117,969,812 90,029,320
Net loss per share of common stock:    
Net loss per share of common stock, basic (in dollars per share) $ (0.08) $ (0.11)
Net loss per share of common stock, diluted (in dollars per share) $ (0.08) $ (0.11)